Creative Medical Company Insiders
| CELZ Stock | USD 2.31 0.12 4.94% |
Creative Medical's insiders are aggressively buying. The analysis of the overall insider sentiment regarding Creative Medical Technology suggests that vertually all insiders are extremely bullish. Creative Medical employs about 4 people. The company is managed by 3 executives with a total tenure of roughly 16 years, averaging almost 5.0 years of service per executive, having 1.33 employees per reported executive.
| Timothy Warbington CEO President CEO, Director |
| Donald Dickerson President CFO, Senior Vice President Director |
Creative Medical's Insider Buying Vs Selling
100
Selling | Buying |
Latest Trades
| 2023-06-27 | Timothy Warbington | Acquired 800 @ 4.44 | View | ||
| 2022-11-21 | Timothy Warbington | Acquired 1500 @ 4 | View | ||
| 2022-09-27 | Timothy Warbington | Acquired 2000 @ 5 | View | ||
| 2022-09-21 | Timothy Warbington | Acquired 3000 @ 6.1 | View | ||
| 2022-06-14 | Michael H Finger | Acquired 1000 @ 7 | View | ||
| 2022-06-06 | Timothy Warbington | Acquired 2500 @ 9.2 | View | ||
| 2022-05-20 | Michael H Finger | Acquired 650 @ 15 | View |
Monitoring Creative Medical's insider sentiment can offer insights into its future performance, as insiders often have access to more information about their company's operations, financial health, and upcoming initiatives than the general public. However, it's essential to note that insider trading is regulated by securities laws, and insiders are required to disclose their trades publicly to ensure transparency and prevent unfair advantages based on non-public information.
Creative |
Creative Medical's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Creative Medical's future performance. Based on our forecasts, it is anticipated that Creative will maintain a workforce of slightly above 7 employees by January 2025.Creative Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.3627) % which means that it has lost $0.3627 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5703) %, meaning that it created substantial loss on money invested by shareholders. Creative Medical's management efficiency ratios could be used to measure how well Creative Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.54 in 2024. Return On Capital Employed is likely to drop to -0.57 in 2024. At this time, Creative Medical's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 10.8 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 401.4 K in 2024.Common Stock Shares Outstanding is likely to rise to about 1.5 M in 2024. Net Income Applicable To Common Shares is likely to rise to about 18.2 M in 2024
Creative Medical Workforce Comparison
Creative Medical Technology is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 243. Creative Medical claims roughly 4.0 in number of employees contributing just under 2% to equities under Health Care industry.
Creative Medical Insider Trading History
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Creative Medical insiders, such as employees or executives, is commonly permitted as long as it does not rely on Creative Medical's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Creative Medical insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
| Buy/Sell Ratio | # Purchases Trades | # Sales Trades | Total Shares Purchased | Total Shares Sold | |
|---|---|---|---|---|---|
| 2021-09-01 | 1.0 | 3 | 3 | 15,000,000 | 4,350,000 |
| 2021-06-01 | 0.5 | 1 | 2 | 10,000,000 | 11,120,448 |
| 2016-12-01 | 0.3333 | 2 | 6 | 1,100,000 | 18,568,018 |
Creative Medical Notable Stakeholders
A Creative Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Creative Medical often face trade-offs trying to please all of them. Creative Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Creative Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Timothy Warbington | President CEO, Director | Profile | |
| Donald Dickerson | CFO, Senior Vice President Director | Profile | |
| Donald MBA | CFO VP | Profile |
About Creative Medical Management Performance
The success or failure of an entity such as Creative Medical Tec often depends on how effective the management is. Creative Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Creative management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Creative management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.51) | (0.54) | |
| Return On Capital Employed | (0.54) | (0.57) | |
| Return On Assets | (0.49) | (0.52) | |
| Return On Equity | (0.51) | (0.54) |
Please note, the imprecision that can be found in Creative Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Creative Medical Technology. Check Creative Medical's Beneish M Score to see the likelihood of Creative Medical's management manipulating its earnings.
Creative Medical Workforce Analysis
Traditionally, organizations such as Creative Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Creative Medical within its industry.Creative Medical Manpower Efficiency
Return on Creative Medical Manpower
| Revenue Per Employee | 2.2K | |
| Revenue Per Executive | 3K | |
| Net Loss Per Employee | 1.3M | |
| Net Loss Per Executive | 1.8M | |
| Working Capital Per Employee | 2.5M | |
| Working Capital Per Executive | 3.3M |
Additional Tools for Creative Stock Analysis
When running Creative Medical's price analysis, check to measure Creative Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creative Medical is operating at the current time. Most of Creative Medical's value examination focuses on studying past and present price action to predict the probability of Creative Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creative Medical's price. Additionally, you may evaluate how the addition of Creative Medical to your portfolios can decrease your overall portfolio volatility.